Antares Pharma, Inc. (NASDAQ: ATRS) announced that the FDA has issued a complete response letter regarding the Abbreviated New Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE